Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period
NCT05144256
- Conditions
- Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Stanford Medicine Palo Alto, California, United States
- Children's Healthcare of Atlanta - Emory Atlanta, Georgia, United States
- Boston Children's Hospital Boston, Massachusetts, United States